Bcl-2 and Ki67 as specific prognostic markers in estrogen receptor positive breast cancers

被引：0
|
作者：
Jasar, D. [1 ]
Filipovski, V. [1 ]
Kubelka-Sabit, K. [1 ]
机构：
[1] Clin Hosp Acibadem Sistina, Dept Histopathol, Skopje, FY, Macedonia
来源：
VIRCHOWS ARCHIV | 2017年 / 471卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
PS-01-017
引用
收藏
页码：S54 / S54
页数：1
相关论文
共 50 条
  • [1] Using Automated Image Analysis To Validate Ki67 as a Clinical Prognostic Biomarker for Estrogen-Receptor Positive Breast Cancers
    Magliocco, A. M.
    Kornaga, E. N.
    Klimowicz, A. C.
    Petrillo, S. K.
    Konno, M.
    Yau, A.
    CANCER RESEARCH, 2010, 70
  • [2] Correlating Ki67 and other prognostic markers with Oncotype DX recurrence score in early estrogen receptor-positive breast cancer
    Tan, Aaron C.
    Li, Bob T.
    Nahar, Kazi
    Danieletto, Suzanne
    Fong, Eva S.
    Currer, Trevor
    Parasyn, Andrew
    Middleton, Philip
    Wong, Heidi
    Smart, Denis
    Rutovitz, Josie J.
    McCloud, Philip
    Hughes, T. Michael
    Marx, Gavin M.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 (02) : E161 - E166
  • [3] Bcl2 and Ki67 refine prognostication in luminal breast cancers
    Lin-Ying Chen
    Julia Y. S. Tsang
    Yun-Bi Ni
    Siu-Ki Chan
    Kui-Fat Chan
    Sheng Zhang
    Gary M. Tse
    Breast Cancer Research and Treatment, 2015, 149 : 631 - 643
  • [4] Bcl2 and Ki67 refine prognostication in luminal breast cancers
    Chen, Lin-Ying
    Tsang, Julia Y. S.
    Ni, Yun-Bi
    Chan, Siu-Ki
    Chan, Kui-Fat
    Zhang, Sheng
    Tse, Gary M.
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 149 (03) : 631 - 643
  • [5] Detecting of gastric cancer by Bcl-2 and Ki67
    Zhou, Yongli
    Li, Yandong
    Zheng, Jianyun
    Liu, Kaige
    Zhang, Hongmei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (06): : 7287 - 7290
  • [6] MODULATION OF BCL-2 AND KI-67 EXPRESSION IN ESTROGEN RECEPTOR-POSITIVE HUMAN BREAST-CANCER BY TAMOXIFEN
    JOHNSTON, SRD
    MACLENNAN, KA
    SACKS, NPM
    SALTER, J
    SMITH, IE
    DOWSETT, M
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (11) : 1663 - 1669
  • [7] Ki67 Heterogeneity in Estrogen Receptor-Positive Breast Cancers: Which Tumor Type Has the Most Heterogeneity?
    Himuro, Takanori
    Horimoto, Yoshiya
    Arakawa, Atsushi
    Tanabe, Masahiko
    Saito, Mitsue
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2016, 24 (02) : 103 - 107
  • [8] Cytological analysis and immunocytochemical expression of Ki67 and Bcl-2 in breast proliferative lesions
    Midulla, C
    Pisani, T
    De Iorio, P
    Cenci, M
    Divizia, E
    Nofroni, I
    Vecchione, A
    ANTICANCER RESEARCH, 2002, 22 (2B) : 1341 - 1345
  • [9] BCL-2 oncogene and Ki-67 antigen expression a correlation between estrogen-receptor positive and negative breast carcinoma
    dos Santos, Lina Gomes
    da Silva, Benedito Borges
    Cunha, Aracy Carstens
    Oliveira, Celio Marcos
    VIRCHOWS ARCHIV, 2007, 451 (02) : 196 - 196
  • [10] Ki67 Expression and Docetaxel Efficacy in Patients With Estrogen Receptor-Positive Breast Cancer
    Penault-Llorca, Frederique
    Andre, Fabrice
    Sagan, Christine
    Lacroix-Triki, Magali
    Denoux, Yves
    Verriele, Veronique
    Jacquemier, Jocelyne
    Baranzelli, Marie Christine
    Bibeau, Frederic
    Antoine, Martine
    Lagarde, Nicole
    Martin, Anne-Laure
    Asselain, Bernard
    Roche, Henri
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (17) : 2809 - 2815
12345